About Iyuda Therapeutics
Iyuda Therapeutics is a private company based in Owings Mills, Maryland. It has reported $4,540,300 raised in five offerings on Form D since September 2023. Its chief executive is Robert Tennant.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Apr 6, 2026 | $599,999fully sold | 2 | $299K | EquityRule 506(b) | Form D ↗ |
| Oct 1, 2024 | Oct 21, 2024amended Jun 6, 2025 | $1,312,337fully sold | 3 | $437K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 30, 2023 | Sep 14, 2023 | $342,722fully sold | 4 | $85,681 | Equity, Includes Units converted into common stockRule 506(b) | Form D ↗ |
| Sep 1, 2023 | Sep 14, 2023 | $1,385,262fully sold | 1 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Aug 30, 2023 | Sep 14, 2023 | $899,980fully sold | 1 | $899K | OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $4,540,300 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Iyuda Therapeutics's Form D filed Apr 6, 2026.
RT
Robert Tennant
Chief Executive Officer
EF
Ephraim Fuchs
Director